Literature DB >> 1959878

Autoantibodies against nuclear envelope proteins in liver disease.

H J Worman1, J C Courvalin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959878

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

Review 1.  Primary biliary cirrhosis. Connecting molecular biology to clinical medicine.

Authors:  S Reynoso-Paz; R L Coppel; Y Nakanuma; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Molecular biology and the diagnosis and treatment of liver diseases.

Authors:  Howard J Worman; Lin Feng; Naoto Mamiya
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

3.  Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome.

Authors:  K Konstantinov; A von Mikecz; D Buchwald; J Jones; L Gerace; E M Tan
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

4.  Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients.

Authors:  A Skowera; E Stewart; E T Davis; A J Cleare; C Unwin; L Hull; K Ismail; G Hossain; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

5.  Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210.

Authors:  R E Nickowitz; H J Worman
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

6.  Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210.

Authors:  J Wesierska-Gadek; H Hohenauer; E Hitchman; E Penner
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

7.  Nup180, a novel nuclear pore complex protein localizing to the cytoplasmic ring and associated fibrils.

Authors:  N Wilken; U Kossner; J L Senécal; U Scheer; M C Dabauvalle
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.